Brief: Mereo Biopharma Prices Underwritten Public Offering Of 34.5 Million ADSS At $2.90 Per ADS
10/02/2021 12:10
Feb 10 (Reuters) - Mereo BioPharma Group plc MAH0y.F :
* MEREO BIOPHARMA GROUP PLC ANNOUNCES PRICING OF PUBLIC
OFFERING
OF AMERICAN DEPOSITARY SHARES
* MEREO BIOPHARMA GROUP PLC - PRICING OF AN UNDERWRITTEN
PUBLIC
OFFERING OF 34.5 MILLION ADSS AT A PUBLIC OFFERING PRICE OF
$2.90 PER ADS
Source text for Eikon: ID:nGNXbK4jY
Further company coverage: MAH0y.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mereo BioPharma
See all newsBrief: Sentynl Therapeutics And Mereo Biopharma Announce Option And License Agreement For Alvelestat In Alpha-1 Antitrypsin Deficiency-Associated Lung Disease
UK's Mereo BioPharma Q2 loss narrows on lower R&D spending
Brief: Mereo BioPharma Q2 Operating Income USD -7.03 Million
Brief: Mereo BioPharma Q1 Net Income USD -6.719 Million
Brief: Mereo BioPharma FY Revenue USD 500 Thousand Vs. IBES Estimate USD 520 Thousand